Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Adrenergic Uptake Inhibitors

Concept
uri icon
  • Overview
scroll to property group menus

Overview

subject area of

  • A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression  Academic Article
  • Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors  Academic Article
  • Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists  Academic Article
  • Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists  Academic Article
  • Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist  Academic Article
  • N-methyl-d-aspartate receptor antagonists enhance the head-twitch response, a 5-hydroxytryptamine(2) receptor-mediated behaviour, in reserpine-treated mice  Academic Article
  • Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine  Academic Article
  • Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores  Academic Article

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support